Fibrinogen Kit

Coagpia Fbg

We created this page for medical staff.

  • *Read carefully the package insert before use.

Performance Data

Within-run reproducibility

(mg/dL)
  Sample 1 Sample 2 Sample 3
1 253 124 84
2 249 116 81
3 255 120 82
4 249 115 82
5 259 115 85
6 255 115 85
7 259 113 88
8 261 116 79
9 247 117 87
10 255 123 85
Mean 254 117 84
S.D. 4.7 3.7 2.8
C.V. (%) 1.9 3.1 3.3
Max. 261 124 88
Min. 247 113 79
Range 14 11 9

On-Board Stability

[on Coapresta 2000]

On-Board Stability

Interference

  Concentration Measured Value(mg/dL)
Base Plasma Spiked Plasma
Unconjugated Bilirubin 25 mg/dL 270 281
Conjugated Bilirubin 25 mg/dL 270 279
Hemoglobin 500 mg/dL 328 330
Chyle 3000 FTU 270 280
Heparin Sodium 8 U/mL 270 259

Linearity

Linearity

Correlation

Correlation

Traceability - Accuracy Verification of Calibrator N for Coagpia

Measured values of Calibrator N for Coagpia were verified using WHO reference material as a calibrator. The closer the measured value is to the calibrator's assigned value (i.e. recovery is closer to 100%), the more closely the sample resembles the reference. Calibrator N for Coagpia was shown to precisely resemble the WHO reference material.

Assay conditions
  • Reagent: Coagpia Fbg
  • Calibrator: WHO 2nd international standard for plasma Fibrinogen NIBSC CODE 98/612 Assigned value 295 mg/dL
  • Analyzer: Coapresta 2000
Sample Measured value with Coagpia Fbg(mg/dL) Mean(mg/dL) Recovery (%)
Calibrator N for Coagpia
Lot A
Assigned value 295mg/dL
305 299.0 101.4
287
305
Calibrator N for Coagpia
Lot B
Assigned value 296mg/dL
298 305.3 103.5
309
309

Assay Procedure

  • Automatic sample dilution
Automatic sample dilution

"Coagpia" is a trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Coapresta" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.

We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.